Novel Antifungal Drug Discovery Based on Targeting Pathways Regulating the Fungus-Conserved Upc2 Transcription Factor
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Infections by Candida albicans and related fungal pathogens pose a serious health problem for immunocompromised patients. Azole drugs, the most common agents used to combat infections, target the sterol biosynthetic pathway. Adaptation to azole therapy develops as drug-stressed cells compensate by upregulating several genes in the pathway, a process mediated in part by the Upc2 transcription factor. We have implemented a cell-based high-throughput screen to identify small-molecule inhibitors of Upc2-dependent induction of sterol gene expression in response to azole drug treatment. The assay is designed to identify not only Upc2 DNA binding inhibitors but also compounds impeding the activation of gene expression by Upc2. An AlphaScreen assay was developed to determine whether the compounds identified interact directly with Upc2 and inhibit DNA binding. Three compounds identified by the cell-based assay inhibited Upc2 protein level and UPC2-LacZ gene expression in response to a block in sterol biosynthesis. The compounds were growth inhibitory and attenuated antifungal-induced sterol gene expression in vivo . They did so by reducing the level of Upc2 protein and Upc2 DNA binding in the presence of drug. The mechanism by which the compounds restrict Upc2 DNA binding is not through a direct interaction, as demonstrated by a lack of DNA binding inhibitory activity using the AlphaScreen assay. Rather, they likely inhibit a novel pathway activating Upc2 in response to a block in sterol biosynthesis. We suggest that the compounds identified represent potential precursors for the synthesis of novel antifungal drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gallo-Ebert et al. found that 3 inhibitors (VB00075177, VB00075853, and VB00074845) reduced the expression of both mRNA and protein levels of UPC2 and demonstrated that these compounds ' inhibiting effect of DNA-binding is irrelevant to the direct interaction with Upc2p.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [58]
Citations
Cites
Transformation of intact yeast cells treated with alkali cations
Ito, H., Fukuda, Y., Murata, K., & Kimura, A. (1983) · Journal of Bacteriology · doi:10.1128/jb.153.1.163-168.1983 · Cited by 7,518
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
[10] Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast
Guarente, L. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)01013-7 · Cited by 1,071
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903 · cited 1×
“glabrata are on the rise, due to acquisition of azole drug resistance (61, 62).”
BackgroundNon-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins
MacPherson, S., Larochelle, M., & Turcotte, B. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-06 · Cited by 612 · cited 3×
“Upc2 is a member of the fungus-conserved Zn2-Cys6 binuclear cluster TFs (25).”
BackgroundInfluentialYeast: An Experimental Organism for 21st Century Biology
Botstein, D., & Fink, G. R. (2011) · Genetics · doi:10.1534/genetics.111.130765 · Cited by 604
Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542
An insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432 · cited 1×
“There are several classes of sterol pathway targeting drugs, the most common being the azoles, which includes the N-substituted imidazoles fluconazole and miconazole and the new triazole derivatives itraconazole and posaconazole (12).”
BackgroundCoste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377 · cited 1×
“glabrata are on the rise, due to acquisition of azole drug resistance (61, 62).”
BackgroundANTIBIOTICS THAT INHIBIT FUNGAL CELL WALL DEVELOPMENT
Debono, M., & Gordee, R. S. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.002351 · Cited by 372 · cited 1×
“Finally, there are the echinocandins that inhibit -glucan synthase, which blocks cell wall biosynthesis (16, 17).”
BackgroundInfection and Diabetes Mellitus
Wheat, L. J. (1980) · Diabetes Care · doi:10.2337/diacare.3.1.187 · Cited by 349 · cited 1×
“Systemic fungal infections are a mortality factor for individuals with HIV (4), and affect the quality of life of elderly diabetics (6, 7).”
BackgroundUpc2p and Ecm22p, Dual Regulators of Sterol Biosynthesis in Saccharomyces cerevisiae
Vik, Å., & Rine, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6395-6405.2001 · Cited by 277 · cited 6×
“An Scupc2 Scecm22 ScUPC2-LacZ null strain had no observable fluconazole-induced SRE activity, as both the ScUpc2 and ScEcm22 transcription factors that bind to SREs were absent (not shown).”
BackgroundInfluentialTriazole Antifungal Agents in Invasive Fungal Infections: A Comparative Review
Lass-Flörl, C. (2011) · Drugs · doi:10.2165/11596540-000000000-00000 · Cited by 270
Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes
de Leon, E. M., Jacober, S. J., Sobel, J. D., & Foxman, B. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-1 · Cited by 248
Candida glabrata, an Emerging Oral Opportunistic Pathogen
Li, L., Redding, S., & Dongari-Bagtzoglou, A. (2007) · Journal of Dental Research · doi:10.1177/154405910708600304 · Cited by 241
Flowers, S. A., Barker, K. S., Berkow, E. L., Toner, G., Chadwick, S. G., Gygax, S. E., Morschhäuser, J., & Rogers, P. D. (2012) · Eukaryotic Cell · doi:10.1128/ec.00215-12 · Cited by 239 · cited 1×
“albicans strains have conserved CaUPC2 gain-of-function mutations that are seen in ScUPC2 alleles conferring resistance (35, 36, 38).”
BackgroundSelf-citationMacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., & Turcotte, B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1745-1752.2005 · Cited by 238 · cited 1×
“Upc2 induces ergosterol biosynthetic gene expression in response to azole antifungal drug treatment (30).”
BackgroundPfeifer, K., Arcangioli, B., & Guarente, L. (1987) · Cell · doi:10.1016/0092-8674(87)90750-1 · Cited by 236
Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhäuser, J., & Rogers, P. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00103-08 · Cited by 236 · cited 2×
“albicans strains have conserved CaUPC2 gain-of-function mutations that are seen in ScUPC2 alleles conferring resistance (35, 36, 38).”
BackgroundLipopeptide inhibitors of fungal glucan synthase
Kurtz, M. B., & Douglas, C. M. (1997) · Medical Mycology · doi:10.1080/02681219780000961 · Cited by 216 · cited 1×
“Finally, there are the echinocandins that inhibit -glucan synthase, which blocks cell wall biosynthesis (16, 17).”
BackgroundRole of Candida albicans Transcription Factor Upc2p in Drug Resistance and Sterol Metabolism
Silver, P. M., Oliver, B. G., & White, T. C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1391-1397.2004 · Cited by 216 · cited 5×
“Strains lacking Upc2 and Ecm22 are sensitive to antifungal treatment and are themselves growth compromised (28).”
BackgroundInfluentialAlarco, A.-M., Balan, I., Talibi, D., Mainville, N., & Raymond, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19304 · Cited by 206
Katiyar, S., Pfaller, M., & Edlind, T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-06 · Cited by 189
Anti-Candida Drugs — The Biochemical Basis for Their Activity
Bossche, H. V., Willemsens, G., & Marichal, P. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104448 · Cited by 144 · cited 1×
“In addition, there are allylamines (terbinafine) (13) and morpholine classes of drugs (fenpropimorph) (14), as well as sterol binders (amphotericin B and nystatin) (15).”
BackgroundHeilmann, C. J., Schneider, S., Barker, K. S., Rogers, P. D., & Morschhäuser, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01102-09 · Cited by 142 · cited 3×
“The UPC2 mutations responsible have been found in resistant clinical isolates, and resistance has been recapitulated in laboratory strains (37, 38).”
BackgroundWei, W., Chua, M., Grepper, S., & So, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.24810 · Cited by 141
Davies, B. S. J., Wang, H. S., & Rine, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7375-7385.2005 · Cited by 138 · cited 3×
“Our efforts have resulted in the identification of three small-molecule compounds inhibiting Upc2-dependent transcriptional signaling in vivo, while also reducing the level of Upc2 that is observed in response to a block in sterol biosynthesis (47).”
BackgroundAbramova, N. E., Cohen, B. D., Sertil, O., Kapoor, R., Davies, K. J. A., & Lowry, C. V. (2001) · Genetics · doi:10.1093/genetics/157.3.1169 · Cited by 128
Crowley, J. H., Leak, F. W., Shianna, K. V., Tove, S., & Parks, L. W. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.16.4177-4183.1998 · Cited by 123 · cited 1×
“Many resistance mechanisms stimulate the overexpression of ERG genes, including gain-of-function mutations in UPC2 (35, 37, 38, 56).”
BackgroundMarcireau, C., Guilloton, M., & Karst, F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.989 · Cited by 122 · cited 1×
“In addition, there are allylamines (terbinafine) (13) and morpholine classes of drugs (fenpropimorph) (14), as well as sterol binders (amphotericin B and nystatin) (15).”
BackgroundZnaidi, S., Weber, S., Zin Al-Abdin, O., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., & Raymond, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00070-08 · Cited by 119 · cited 2×
“Binding to the consensus SRE from CaERG2 was determined (31).”
BackgroundTuri, T. G., & Loper, J. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46051-6 · Cited by 117
Hoot, S. J., Smith, A. R., Brown, R. P., & White, T. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00995-10 · Cited by 107 · cited 2×
“The UPC2 mutations responsible have been found in resistant clinical isolates, and resistance has been recapitulated in laboratory strains (37, 38).”
BackgroundOdds, F. C., Webster, C. E., Mayuranathan, P., & Simmons, P. D. (1988) · Medical Mycology · doi:10.1080/02681218880000391 · Cited by 99
Terbinafine: a pharmacological and clinical review
Krishnan-Natesan, S. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903307462 · Cited by 99 · cited 1×
“In addition, there are allylamines (terbinafine) (13) and morpholine classes of drugs (fenpropimorph) (14), as well as sterol binders (amphotericin B and nystatin) (15).”
BackgroundBiochemistry and Molecular Biology of Sterol Synthesis in Saccharomyces cerevisiae
Lees, N. D., Bard, M., & Kirsch, D. R. (2020) · BIOCHEMISTRY and FUNCTION of STEROLS · doi:10.1201/9781003068754-6 · Cited by 98
MacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98
Sasse, C., Dunkel, N., Schäfer, T., Schneider, S., Dierolf, F., Ohlsen, K., & Morschhäuser, J. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08210.x · Cited by 93
BIOCHEMISTRY and FUNCTION of STEROLS
Parish, E. J., & Nes, W. D. (2020) · CRC Press eBooks · doi:10.1201/9781003068754 · Cited by 90
Cohen, B. D. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.799 · Cited by 88
Organ Protection by Hypoxia and Hypoxia‐Inducible Factors
Bernhardt, W. M., Warnecke, C., Willam, C., Tanaka, T., Wiesener, M. S., & Eckardt, K. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35012-x · Cited by 73
Hongay, C., Jia, N., Bard, M., & Winston, F. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf415 · Cited by 72
Nagi, M., Nakayama, H., Tanabe, K., Bard, M., Aoyama, T., Okano, M., Higashi, S., Ueno, K., Chibana, H., Niimi, M., et al. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01470.x · Cited by 68 · cited 1×
“This seems reasonable since Scecm22 Scupc2 double null cells are viable, although their growth is compromised (28, 29).”
BackgroundJones, D. T., & Harris, A. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0443 · Cited by 68
Small Molecule Modulators of Transcription
Arndt, H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600285 · Cited by 68
Rox3 and Rts1 Function in the Global Stress Response Pathway in Baker's Yeast
Evangelista, C. C., Torres, A. M. R., Limbach, M. P., & Zitomer, R. S. (1996) · Genetics · doi:10.1093/genetics/142.4.1083 · Cited by 67
Shianna, K. V., Dotson, W. D., Tove, S., & Parks, L. W. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.830-834.2001 · Cited by 63 · cited 6×
“An Scupc2 Scecm22 ScUPC2-LacZ null strain had no observable fluconazole-induced SRE activity, as both the ScUpc2 and ScEcm22 transcription factors that bind to SREs were absent (not shown).”
BackgroundInfluentialGrishin, A. V., Rothenberg, M., Downs, M. A., & Blumer, K. J. (1998) · Genetics · doi:10.1093/genetics/149.2.879 · Cited by 58
Ratan, R. R., Siddiq, A., Aminova, L., Langley, B., McConoughey, S., Karpisheva, K., Lee, H., Carmichael, T., Kornblum, H., Coppola, G., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.033 · Cited by 57
Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules
Berg, T. (2008) · ChemBioChem · doi:10.1002/cbic.200800274 · Cited by 53
Oliver, B. G., Song, J. L., Choiniere, J. H., & White, T. C. (2007) · Eukaryotic Cell · doi:10.1128/ec.00331-06 · Cited by 53 · cited 1×
“It represents an excellent target for compound discovery, as inhibition would circumvent multiple resistance mechanisms upregulating ERG genes (54).”
BackgroundTargeting NF-κB: A Promising Molecular Therapy in Inflammatory Arthritis
Roman‐Blas, J. A., & Jiménez, S. A. (2008) · International Reviews of Immunology · doi:10.1080/08830180802295740 · Cited by 51
Vazquez, J. A., Sobel, J. D., Peng, G., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. I. A. (1999) · Clinical Infectious Diseases · doi:10.1086/514746 · Cited by 51 · cited 2×
“Candida species cause systemic infections in the immunocom-promised, such as HIV patients, those receiving cancer chemotherapy, and organ transplant patients (1–5).”
BackgroundEchinocandins: Are They All The Same?
Mukherjee, P., Sheehan, D., Puzniak, L., Schlamm, H., & Ghannoum, M. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.6.319 · Cited by 45
Hoot, S. J., Oliver, B. G., & White, T. C. (2008) · Microbiology · doi:10.1099/mic.0.2008/017475-0 · Cited by 39 · cited 2×
“albicans uses other transcription factors to regulate ERG gene expression in addition to CaUpc2 (32, 63).”
BackgroundEfficacy and Safety of Current Drug Therapies for Invasive Aspergillosis
Traunmüller, F., Popovic, M., Konz, K.-H., Smolle‐Jüttner, F., & Joukhadar, C. (2011) · Pharmacology · doi:10.1159/000331860 · Cited by 38
Bialkowska, A. B., Du, Y., Fu, H., & Yang, V. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0767 · Cited by 35
Germann, M., Gallo, C., Donahue, T., Shirzadi, R., Stukey, J., Lang, S., Ruckenstuhl, C., Oliaro-Bosso, S., McDonough, V., Turnowsky, F., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504978200 · Cited by 33
Self-citationHit finding: towards ‘smarter’ approaches
Langer, T., Hoffmann, R. D., Bryant, S. D., & Lesur, B. M. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.001 · Cited by 32
Cartwright, R. Y. (1975) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/1.2.141 · Cited by 30
CANDIDA FASCIITIS FOLLOWING RENAL TRANSPLANTATION
Wai, P. H., Ewing, C. A., Johnson, L. B., Lu, A. D., Attinger, C. E., & Kuo, P. C. (2001) · Transplantation · doi:10.1097/00007890-200108150-00019 · Cited by 26
Hoot, S. J., Brown, R. P., Oliver, B. G., & White, T. C. (2010) · Eukaryotic Cell · doi:10.1128/ec.00130-10 · Cited by 25 · cited 2×
“albicans uses other transcription factors to regulate ERG gene expression in addition to CaUpc2 (32, 63).”
BackgroundPP2ACdc55is required for multiple events during meiosis I
Nolt, J. K., Rice, L. M., Ebert, C., Bisher, M. E., & Nickels, J. T. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15485 · Cited by 18
Self-citationHerrero, E. (2005) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(05)70046-2 · Cited by 16
Gallo-Ebert, C., Donigan, M., Liu, H.-Y., Pascual, F., Manners, M., Pandya, D., Swanson, R., Gallagher, D., Chen, W., Carman, G. M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526087 · Cited by 11
Self-citationGeile, D., & Stahl, R. (1993) · Cited by 11
Cited by
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866
Kumari, A., & Singh, R. K. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103578 · Cited by 244
Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2
Yang, H., Tong, J., Lee, C. W., Ha, S., Eom, S. H., & Im, Y. J. (2015) · Nature Communications · doi:10.1038/ncomms7129 · Cited by 223
Antifungals: Mechanism of Action and Drug Resistance
Prasad, R., Shah, A. H., & Rawal, M. K. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_14 · Cited by 183
Antifungal drugs: New insights in research & development
Nicola, A. M., Albuquerque, P., Paes, H. C., Fernandes, L., Costa, F. F., Kioshima, E. S., Abadio, A. K. R., Bocca, A. L., & Felipe, M. S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.008 · Cited by 139
Metadata
- Authors
- Gallo-Ebert, C., Donigan, M., Stroke, I. L., Swanson, R. N., Manners, M. T., Francisco, J., Toner, G., Gallagher, D., Huang, C.-Y., Gygax, S. E., Webb, M., & Nickels, J. T.
- Affiliations
- The Institute of Metabolic Disorders, Genesis Biotechnology Group, Hamilton, New Jersey, USA
- Venenum Biodesign, Genesis Biotechnology Group, Hamilton, New Jersey, USA
- Femeris, Women's Health Research Center, Medical Diagnostic Laboratories, Genesis Biotechnology Group, Hamilton, New Jersey, USA
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-01
- Volume
- 58
- Issue
- 1
- Pages
- 258-266
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3910738
- OpenAlex
- W2099462216
- Cited by
- 32
- References
- 69
- Citations by year
- 2026: 2 · 2025: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 2
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- antifungal drug discovery, Candida albicans, azole resistance, sterol biosynthesis, small molecule inhibitors, AlphaScreen, high-throughput screening, fungal pathogens
- MeSH terms
- Antifungal Agents, Candida albicans, Fungal Proteins, Transcription Factors, Signal Transduction, Gene Expression Regulation, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.